Exhibit 99.1
JOINT FILING AGREEMENT
The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.01 per share, of EyeGate Pharmaceuticals, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
August 20, 2021
| | | |
| LIND GLOBAL FUND II LP |
| | |
By: | | Lind Global Partners II LLC |
| | | its General Partner |
| | |
By: | | |
Name: | | Jeff Easton |
Title: | | Managing Member |
| |
| LIND GLOBAL PARTNERS II LLC |
| | |
By: | | |
Name: | | Jeff Easton |
Title: | | Managing Member |
| |
| JEFF EASTON |
| |
By: | | |
Name: | | Jeff Easton |
